Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 154 entries
Sorted by: Best Match Show Resources per page
Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Neuro-oncology practice

Câmara-Costa H, Bull KS, Kennedy C, Wiener A, Calaminus G, Resch A, Kieffer V, Lalande C, Poggi G, von Hoff K, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M.
PMID: 31385949
Neurooncol Pract. 2017 Sep;4(3):161-170. doi: 10.1093/nop/npw028. Epub 2017 Feb 10.

BACKGROUND: The relationship between direct assessments of cognitive performance and questionnaires assessing quality of survival (QoS) is reported to be weak-to-nonexistent. Conversely, the associations between questionnaires evaluating distinct domains of QoS tend to be strong. This pattern remains understudied.METHODS:...

Cite
Câmara-Costa H, Bull KS, Kennedy C, et al. Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial. Neurooncol Pract. 2017;4(3):161-170doi: 10.1093/nop/npw028.
Câmara-Costa, H., Bull, K. S., Kennedy, C., Wiener, A., Calaminus, G., Resch, A., Kieffer, V., Lalande, C., Poggi, G., von Hoff, K., Grill, J., Doz, F., Rutkowski, S., Massimino, M., Kortmann, R. D., Lannering, B., Dellatolas, G., Chevignard, M. (2017). Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial. Neuro-oncology practice, 4(3), 161-170. https://doi.org/10.1093/nop/npw028
Câmara-Costa, Hugo, et al. "Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial." Neuro-oncology practice vol. 4,3 (2017): 161-170. doi: https://doi.org/10.1093/nop/npw028
Câmara-Costa H, Bull KS, Kennedy C, Wiener A, Calaminus G, Resch A, Kieffer V, Lalande C, Poggi G, von Hoff K, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M. Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial. Neurooncol Pract. 2017 Sep;4(3):161-170. doi: 10.1093/nop/npw028. Epub 2017 Feb 10. PMID: 31385949; PMCID: PMC6655414.
Copy Download .nbib Format: NLM
Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury.

Neural regeneration research

Ortmann SD, Hellenbrand DJ.
PMID: 30136685
Neural Regen Res. 2018 Oct;13(10):1733-1734. doi: 10.4103/1673-5374.238610.

No abstract available.

Cite
Ortmann SD, Hellenbrand DJ. Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury. Neural Regen Res. 2018;13(10):1733-1734doi: 10.4103/1673-5374.238610.
Ortmann, S. D., & Hellenbrand, D. J. (2018). Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury. Neural regeneration research, 13(10), 1733-1734. https://doi.org/10.4103/1673-5374.238610
Ortmann, Stephen D, and Hellenbrand, Daniel J. "Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury." Neural regeneration research vol. 13,10 (2018): 1733-1734. doi: https://doi.org/10.4103/1673-5374.238610
Ortmann SD, Hellenbrand DJ. Glial cell line-derived neurotrophic factor as a treatment after spinal cord injury. Neural Regen Res. 2018 Oct;13(10):1733-1734. doi: 10.4103/1673-5374.238610. PMID: 30136685; PMCID: PMC6128059.
Copy Download .nbib Format: NLM
S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S.
PMID: 31241846
J Dtsch Dermatol Ges. 2019 Jun;17(6):663-668. doi: 10.1111/ddg.13849_g.

No abstract available.

Cite
Ugurel S, Kortmann RD, Mohr P, et al. S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018. J Dtsch Dermatol Ges. 2019;17(6):663-668doi: 10.1111/ddg.13849_g.
Ugurel, S., Kortmann, R. D., Mohr, P., Mentzel, T., Garbe, C., Breuninger, H., Bauer, S., & Grabbe, S. (2019). S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 17(6), 663-668. https://doi.org/10.1111/ddg.13849_g
Ugurel, Selma, et al. "S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 17,6 (2019): 663-668. doi: https://doi.org/10.1111/ddg.13849_g
Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S. S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018. J Dtsch Dermatol Ges. 2019 Jun;17(6):663-668. doi: 10.1111/ddg.13849_g. PMID: 31241846.
Copy Download .nbib Format: NLM
A decline in global CFC-11 emissions during 2018-2019.

Nature

Montzka SA, Dutton GS, Portmann RW, Chipperfield MP, Davis S, Feng W, Manning AJ, Ray E, Rigby M, Hall BD, Siso C, Nance JD, Krummel PB, Mühle J, Young D, O'Doherty S, Salameh PK, Harth CM, Prinn RG, Weiss RF, Elkins JW, Walter-Terrinoni H, Theodoridi C.
PMID: 33568809
Nature. 2021 Feb;590(7846):428-432. doi: 10.1038/s41586-021-03260-5. Epub 2021 Feb 10.

The atmospheric concentration of trichlorofluoromethane (CFC-11) has been in decline since the production of ozone-depleting substances was phased out under the Montreal Protocol

Cite
Montzka SA, Dutton GS, Portmann RW, et al. A decline in global CFC-11 emissions during 2018-2019. Nature. 2021;590(7846):428-432doi: 10.1038/s41586-021-03260-5.
Montzka, S. A., Dutton, G. S., Portmann, R. W., Chipperfield, M. P., Davis, S., Feng, W., Manning, A. J., Ray, E., Rigby, M., Hall, B. D., Siso, C., Nance, J. D., Krummel, P. B., Mühle, J., Young, D., O'Doherty, S., Salameh, P. K., Harth, C. M., Prinn, R. G., Weiss, R. F., Elkins, J. W., Walter-Terrinoni, H., & Theodoridi, C. (2021). A decline in global CFC-11 emissions during 2018-2019. Nature, 590(7846), 428-432. https://doi.org/10.1038/s41586-021-03260-5
Montzka, Stephen A, et al. "A decline in global CFC-11 emissions during 2018-2019." Nature vol. 590,7846 (2021): 428-432. doi: https://doi.org/10.1038/s41586-021-03260-5
Montzka SA, Dutton GS, Portmann RW, Chipperfield MP, Davis S, Feng W, Manning AJ, Ray E, Rigby M, Hall BD, Siso C, Nance JD, Krummel PB, Mühle J, Young D, O'Doherty S, Salameh PK, Harth CM, Prinn RG, Weiss RF, Elkins JW, Walter-Terrinoni H, Theodoridi C. A decline in global CFC-11 emissions during 2018-2019. Nature. 2021 Feb;590(7846):428-432. doi: 10.1038/s41586-021-03260-5. Epub 2021 Feb 10. PMID: 33568809.
Copy Download .nbib Format: NLM
[Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease].

Der Nervenarzt

Hoppe J, Kalckreuth T, Metelmann M, Rumpf JJ, Klagges S, Dietzsch S, Scherlach C, Kuhnt T, Kortmann RD, Seidel C.
PMID: 35024880
Nervenarzt. 2022 Jan 13; doi: 10.1007/s00115-021-01229-3. Epub 2022 Jan 13.

BACKGROUND AND PURPOSE: Skull base metastases are a severe complication of various malignant tumors. If cranial nerves are involved even small lesions can cause significant symptoms. Specific clinical characteristics like neurological symptoms, associated primary tumors, prognosis and optimal treatment...

Cite
Hoppe J, Kalckreuth T, Metelmann M, et al. Schädelbasismetastasen mit Hirnnervenaffektionen : Klinischer Steckbrief einer schwerwiegenden Erkrankung. [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Nervenarzt. 2022;doi: 10.1007/s00115-021-01229-3.
Hoppe, J., Kalckreuth, T., Metelmann, M., Rumpf, J. J., Klagges, S., Dietzsch, S., Scherlach, C., Kuhnt, T., Kortmann, R. D., & Seidel, C. (2022). Schädelbasismetastasen mit Hirnnervenaffektionen : Klinischer Steckbrief einer schwerwiegenden Erkrankung. [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Der Nervenarzt, . https://doi.org/10.1007/s00115-021-01229-3
Hoppe, J, et al. "Schädelbasismetastasen mit Hirnnervenaffektionen : Klinischer Steckbrief einer schwerwiegenden Erkrankung." [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Der Nervenarzt vol. (2022). doi: https://doi.org/10.1007/s00115-021-01229-3
Hoppe J, Kalckreuth T, Metelmann M, Rumpf JJ, Klagges S, Dietzsch S, Scherlach C, Kuhnt T, Kortmann RD, Seidel C. Schädelbasismetastasen mit Hirnnervenaffektionen : Klinischer Steckbrief einer schwerwiegenden Erkrankung. [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease]. Nervenarzt. 2022 Jan 13; doi: 10.1007/s00115-021-01229-3. Epub 2022 Jan 13. German. PMID: 35024880.
Copy Download .nbib Format: NLM
Serum Metabolites Responding in a Dose-Dependent Manner to the Intake of a High-Fat Meal in Normal Weight Healthy Men Are Associated with Obesity.

Metabolites

Bütikofer U, Burnand D, Portmann R, Blaser C, Schwander F, Kopf-Bolanz KA, Laederach K, Badertscher R, Walther B, Vergères G.
PMID: 34208710
Metabolites. 2021 Jun 16;11(6). doi: 10.3390/metabo11060392.

Although the composition of the human blood metabolome is influenced both by the health status of the organism and its dietary behavior, the interaction between these two factors has been poorly characterized. This study makes use of a previously...

Cite
Bütikofer U, Burnand D, Portmann R, et al. Serum Metabolites Responding in a Dose-Dependent Manner to the Intake of a High-Fat Meal in Normal Weight Healthy Men Are Associated with Obesity. Metabolites. 2021;11(6)doi: 10.3390/metabo11060392.
Bütikofer, U., Burnand, D., Portmann, R., Blaser, C., Schwander, F., Kopf-Bolanz, K. A., Laederach, K., Badertscher, R., Walther, B., & Vergères, G. (2021). Serum Metabolites Responding in a Dose-Dependent Manner to the Intake of a High-Fat Meal in Normal Weight Healthy Men Are Associated with Obesity. Metabolites, 11(6), . https://doi.org/10.3390/metabo11060392
Bütikofer, Ueli, et al. "Serum Metabolites Responding in a Dose-Dependent Manner to the Intake of a High-Fat Meal in Normal Weight Healthy Men Are Associated with Obesity." Metabolites vol. 11,6 (2021). doi: https://doi.org/10.3390/metabo11060392
Bütikofer U, Burnand D, Portmann R, Blaser C, Schwander F, Kopf-Bolanz KA, Laederach K, Badertscher R, Walther B, Vergères G. Serum Metabolites Responding in a Dose-Dependent Manner to the Intake of a High-Fat Meal in Normal Weight Healthy Men Are Associated with Obesity. Metabolites. 2021 Jun 16;11(6). doi: 10.3390/metabo11060392. PMID: 34208710; PMCID: PMC8233812.
Copy Download .nbib Format: NLM
Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.

Cancers

Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD.
PMID: 34885055
Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235945.

Medulloblastoma is the most frequent malignant brain tumor in children. During the last decades, the therapeutic landscape has changed significantly with craniospinal irradiation as the backbone of treatment. Survival times have increased and treatments were stratified according to clinical...

Cite
Seidel C, Heider S, Hau P, et al. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235945.
Seidel, C., Heider, S., Hau, P., Glasow, A., Dietzsch, S., & Kortmann, R. D. (2021). Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives. Cancers, 13(23), . https://doi.org/10.3390/cancers13235945
Seidel, Clemens, et al. "Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235945
Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives. Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235945. PMID: 34885055.
Copy Download .nbib Format: NLM
Digitalisation and Employees' Subjective Job Quality in the Second Half of Working Life in Germany.

Social indicators research

Kortmann LK, Simonson J, Vogel C, Huxhold O.
PMID: 34873360
Soc Indic Res. 2021 Dec 01;1-21. doi: 10.1007/s11205-021-02854-w. Epub 2021 Dec 01.

Since digitalisation alters occupational task profiles via automation processes, job quality is also likely to be affected. While existing literature mainly focusses on objective job quality, this study asks if and how digitalisation is associated with employees' subjective job...

Cite
Kortmann LK, Simonson J, Vogel C, et al. Digitalisation and Employees' Subjective Job Quality in the Second Half of Working Life in Germany. Soc Indic Res. 2021;1-21doi: 10.1007/s11205-021-02854-w.
Kortmann, L. K., Simonson, J., Vogel, C., & Huxhold, O. (2021). Digitalisation and Employees' Subjective Job Quality in the Second Half of Working Life in Germany. Social indicators research, 1-21. https://doi.org/10.1007/s11205-021-02854-w
Kortmann, Lisa Katharina, et al. "Digitalisation and Employees' Subjective Job Quality in the Second Half of Working Life in Germany." Social indicators research vol. (2021): 1-21. doi: https://doi.org/10.1007/s11205-021-02854-w
Kortmann LK, Simonson J, Vogel C, Huxhold O. Digitalisation and Employees' Subjective Job Quality in the Second Half of Working Life in Germany. Soc Indic Res. 2021 Dec 01;1-21. doi: 10.1007/s11205-021-02854-w. Epub 2021 Dec 01. PMID: 34873360; PMCID: PMC8635314.
Copy Download .nbib Format: NLM
Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches.

Metabolites

Li KJ, Burton-Pimentel KJ, Brouwer-Brolsma EM, Feskens EJM, Blaser C, Badertscher R, Portmann R, Vergères G.
PMID: 34204298
Metabolites. 2021 Jun 17;11(6). doi: 10.3390/metabo11060395.

Studies examining associations between self-reported dairy intake and health are inconclusive, but biomarkers hold promise for elucidating such relationships by offering objective measures of dietary intake. Previous human intervention studies identified several biomarkers for dairy foods in blood and...

Cite
Li KJ, Burton-Pimentel KJ, Brouwer-Brolsma EM, et al. Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches. Metabolites. 2021;11(6)doi: 10.3390/metabo11060395.
Li, K. J., Burton-Pimentel, K. J., Brouwer-Brolsma, E. M., Feskens, E. J. M., Blaser, C., Badertscher, R., Portmann, R., & Vergères, G. (2021). Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches. Metabolites, 11(6), . https://doi.org/10.3390/metabo11060395
Li, Katherine J, et al. "Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches." Metabolites vol. 11,6 (2021). doi: https://doi.org/10.3390/metabo11060395
Li KJ, Burton-Pimentel KJ, Brouwer-Brolsma EM, Feskens EJM, Blaser C, Badertscher R, Portmann R, Vergères G. Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches. Metabolites. 2021 Jun 17;11(6). doi: 10.3390/metabo11060395. PMID: 34204298; PMCID: PMC8235731.
Copy Download .nbib Format: NLM
Recurrence of Pathologically Proven Papillary Fibroelastoma.

The Annals of thoracic surgery

Sorour AA, Kurmann RD, El-Am EA, Bois MC, Scott CG, Lee AT, Dearani JA, Maleszewski JJ, Klarich KW.
PMID: 34022212
Ann Thorac Surg. 2021 May 19; doi: 10.1016/j.athoracsur.2021.03.114. Epub 2021 May 19.

BACKGROUND: Papillary fibroelastoma (PFE) is the most common primary benign cardiac tumor. Because PFEs have the potential to embolize, they often are surgically excised. Prior studies have suggested that postoperative recurrence of PFE is rare or does not occur....

Cite
Sorour AA, Kurmann RD, El-Am EA, et al. Recurrence of Pathologically Proven Papillary Fibroelastoma. Ann Thorac Surg. 2021;doi: 10.1016/j.athoracsur.2021.03.114.
Sorour, A. A., Kurmann, R. D., El-Am, E. A., Bois, M. C., Scott, C. G., Lee, A. T., Dearani, J. A., Maleszewski, J. J., & Klarich, K. W. (2021). Recurrence of Pathologically Proven Papillary Fibroelastoma. The Annals of thoracic surgery, . https://doi.org/10.1016/j.athoracsur.2021.03.114
Sorour, Ahmed A, et al. "Recurrence of Pathologically Proven Papillary Fibroelastoma." The Annals of thoracic surgery vol. (2021). doi: https://doi.org/10.1016/j.athoracsur.2021.03.114
Sorour AA, Kurmann RD, El-Am EA, Bois MC, Scott CG, Lee AT, Dearani JA, Maleszewski JJ, Klarich KW. Recurrence of Pathologically Proven Papillary Fibroelastoma. Ann Thorac Surg. 2021 May 19; doi: 10.1016/j.athoracsur.2021.03.114. Epub 2021 May 19. PMID: 34022212.
Copy Download .nbib Format: NLM
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.

Molecular oncology

Waldeck S, Mitschke J, Wiesemann S, Rassner M, Andrieux G, Deuter M, Mutter J, Lüchtenborg AM, Kottmann D, Titze L, Zeisel C, Jolic M, Philipp U, Lassmann S, Bronsert P, Greil C, Rawluk J, Becker H, Isbell L, Müller A, Doostkam S, Passlick B, Börries M, Duyster J, Wehrle J, Scherer F, von Bubnoff N.
PMID: 34653314
Mol Oncol. 2021 Oct 15; doi: 10.1002/1878-0261.13116. Epub 2021 Oct 15.

Circulating tumor DNA (ctDNA) has demonstrated great potential as a noninvasive biomarker to assess minimal residual disease (MRD) and profile tumor genotypes in patients with non-small-cell lung cancer (NSCLC). However, little is known about its dynamics during and after...

Cite
Waldeck S, Mitschke J, Wiesemann S, et al. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Mol Oncol. 2021;doi: 10.1002/1878-0261.13116.
Waldeck, S., Mitschke, J., Wiesemann, S., Rassner, M., Andrieux, G., Deuter, M., Mutter, J., Lüchtenborg, A. M., Kottmann, D., Titze, L., Zeisel, C., Jolic, M., Philipp, U., Lassmann, S., Bronsert, P., Greil, C., Rawluk, J., Becker, H., Isbell, L., Müller, A., Doostkam, S., Passlick, B., Börries, M., Duyster, J., Wehrle, J., Scherer, F., & von Bubnoff, N. (2021). Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Molecular oncology, . https://doi.org/10.1002/1878-0261.13116
Waldeck, Silvia, et al. "Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13116
Waldeck S, Mitschke J, Wiesemann S, Rassner M, Andrieux G, Deuter M, Mutter J, Lüchtenborg AM, Kottmann D, Titze L, Zeisel C, Jolic M, Philipp U, Lassmann S, Bronsert P, Greil C, Rawluk J, Becker H, Isbell L, Müller A, Doostkam S, Passlick B, Börries M, Duyster J, Wehrle J, Scherer F, von Bubnoff N. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Mol Oncol. 2021 Oct 15; doi: 10.1002/1878-0261.13116. Epub 2021 Oct 15. PMID: 34653314.
Copy Download .nbib Format: NLM
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies.

Journal of neuro-oncology

Adolph JE, Fleischhack G, Gaab C, Mikasch R, Mynarek M, Rutkowski S, Schüller U, Pfister SM, Pajtler KW, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Tippelt S.
PMID: 34657224
J Neurooncol. 2021 Nov;155(2):193-202. doi: 10.1007/s11060-021-03867-8. Epub 2021 Oct 16.

PURPOSE: Survival in recurrent ependymoma (EPN) depends mainly on the extent of resection achieved. When complete resection is not feasible, chemotherapy is often used to extend progression-free and overall survival. However, no consistent effect of chemotherapy on survival has...

Cite
Adolph JE, Fleischhack G, Gaab C, et al. Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies. J Neurooncol. 2021;155(2):193-202doi: 10.1007/s11060-021-03867-8.
Adolph, J. E., Fleischhack, G., Gaab, C., Mikasch, R., Mynarek, M., Rutkowski, S., Schüller, U., Pfister, S. M., Pajtler, K. W., Milde, T., Witt, O., Bison, B., Warmuth-Metz, M., Kortmann, R. D., Dietzsch, S., Pietsch, T., Timmermann, B., Tippelt, S. (2021). Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies. Journal of neuro-oncology, 155(2), 193-202. https://doi.org/10.1007/s11060-021-03867-8
Adolph, Jonas E, et al. "Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies." Journal of neuro-oncology vol. 155,2 (2021): 193-202. doi: https://doi.org/10.1007/s11060-021-03867-8
Adolph JE, Fleischhack G, Gaab C, Mikasch R, Mynarek M, Rutkowski S, Schüller U, Pfister SM, Pajtler KW, Milde T, Witt O, Bison B, Warmuth-Metz M, Kortmann RD, Dietzsch S, Pietsch T, Timmermann B, Tippelt S. Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies. J Neurooncol. 2021 Nov;155(2):193-202. doi: 10.1007/s11060-021-03867-8. Epub 2021 Oct 16. PMID: 34657224; PMCID: PMC8585796.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 154 entries